TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31086222
Drug: Iranian propolis
Normalized name: propolis
DrugBank: Sodium fluorophosphate (DB09484)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Iranian propolis (1000 mg/day)
Study: 8542165
Drug: Budesonide 400
Normalized name: Budesonide 400 microgram/actuation powder for inhalation
Approvals — FDA: no, EMA: no, PMDA: no
Description: Budesonide 400 micrograms three times daily
Study: 20406154
Drug: Being driven
Normalized name: norethindrone
DrugBank: Norethisterone (DB00717)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Being driven to school daily
Study: 19114261
Drug: Mindfulness meditation
Normalized name: benzalkonium chloride Topical Foam [Meditize]
Approvals — FDA: no, EMA: no, PMDA: no
Description: Mindfulness meditation combined with cognitive behavioral therapy for insomnia (CBT-I)
Study: 25436803
Drug: Docetaxel alone
Normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Docetaxel alone (75 mg/m intravenously, every 21 days)
Study: 19681657
Drug: 36 g
Normalized name: ARBUTIN 0.36 g in 5 g CUTANEOUS LIQUID
Approvals — FDA: no, EMA: no, PMDA: no
Description: 36 g alcohol daily
Study: 7051813
Drug: Oral erythromycin
Normalized name: Erythromycin
DrugBank: Erythromycin (DB00199)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Oral erythromycin therapy (for relapses)
Study: 11316647
Drug: Tetracaine aerosol
Normalized name: Tetracaine
DrugBank: Tetracaine (DB09085)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Tetracaine aerosol inhalation
Study: 26585393
Drug: Problem-Solving Therapy
Normalized name: Monistat Simple Therapy
Approvals — FDA: no, EMA: no, PMDA: no
Description: Problem-Solving Therapy (PST) as add-on to standard outpatient rehabilitation
Study: 10808701
Drug: 17 beta-estradiol
Normalized name: 17 beta-estradiol
Approvals — FDA: no, EMA: no, PMDA: no
Description: 17 beta-estradiol 2 mg and norethisterone acetate 1 mg
Study: 12610862
Drug: Combination of
Normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
Approvals — FDA: no, EMA: no, PMDA: no
Description: Combination of new active agents (paclitaxel, gemcitabine, irinotecan)
Study: 8740091
Drug: Test formulation
Normalized name: mumps skin test antigen
Approvals — FDA: no, EMA: no, PMDA: no
Description: Test formulation (T) of N-desmethyl-tamoxifen
Study: 22386829
Drug: Amlodipine 10
Normalized name: amlodipine 10 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: Amlodipine 10 mg (A)
Study: 14973517
Drug: Enalapril 10
Normalized name: enalapril 10 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: Enalapril 10 mg/nitrendipine 20 mg (E/N)
Study: 7943832
Drug: Propofol plus
Normalized name: Propofol
DrugBank: Propofol (DB00818)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Propofol plus fentanyl (1 ng/ml)
Study: 7943832
Drug: Propofol plus
Normalized name: Propofol
DrugBank: Propofol (DB00818)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Propofol plus fentanyl (3 ng/ml)
Study: 16413495
Drug: Cognitive therapy
Normalized name: cognitive therapy software
Approvals — FDA: no, EMA: no, PMDA: no
Description: Cognitive therapy administered in small groups
Study: 15498183
Drug: Metformin only
Normalized name: Metformin only product
Approvals — FDA: no, EMA: no, PMDA: no
Description: Metformin only (Group B)
Study: 24176495
Drug: Late vaccination
Normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Late vaccination (day 16 after chemotherapy)
Study: 8287830
Drug: Anti-thyroid therapy
Normalized name: Thyroid
DrugBank: Thyroid, porcine (DB09100)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Anti-thyroid therapy
Study: 8287830
Drug: Propranolol 160
Normalized name: propranolol 160 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: Propranolol 160 mg/day for 28 days
Study: 10460199
Drug: Nocturnal oral
Normalized name: Nocdurna Oral Product
Approvals — FDA: no, EMA: no, PMDA: no
Description: Nocturnal oral fat load test (OFLT) at 2200 h
Study: 7791836
Drug: Magnesium sulfate
Normalized name: Magnesium Sulfate
DrugBank: Magnesium (DB14513)
Approvals — FDA: yes, EMA: no, PMDA: yes
Description: Magnesium sulfate (10-g intramuscular loading dose followed by 5 g every four hours; additional 4-g loading dose intravenously for severe preeclampsia)
Study: 20560804
Drug: Occupational Therapy
Normalized name: Monistat Simple Therapy
Approvals — FDA: no, EMA: no, PMDA: no
Description: Occupational Therapy (OT) program
Study: 22006541
Drug: 40 mg
Normalized name: rutin 40 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: 40 mg GS-9450
Study: 25914483
Drug: Antibiotic group
Normalized name: Streptococcus viridans group
Approvals — FDA: no, EMA: no, PMDA: no
Description: Antibiotic group (cefuroxime 1.5 g iv half an hour before and 6 h after surgery)
Study: 7775727
Drug: 24 g
Normalized name: glucose 24 g/31 g oral gel
Approvals — FDA: no, EMA: no, PMDA: no
Description: 24 g psyllium fiber daily for 1 month
Study: 1499598
Drug: Moxonidine 0.2
Normalized name: moxonidine 0.2 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: Moxonidine 0.2 mg non-fasting
Study: 10522614
Drug: Interferon-alpha-2b and
Normalized name: Interferon alpha-2B
DrugBank: Interferon alfa-2b (DB00105)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Interferon-alpha-2b and ribavirin (combination therapy)
Study: 30735073
Drug: DHA (3
Normalized name: Gesticare DHA (30) Pack
Approvals — FDA: no, EMA: no, PMDA: no
Description: DHA (3 g/day)
Study: 20817132
Drug: Transdermal nitroglycerin
Normalized name: nitroglycerin Transdermal System
DrugBank: Nitroglycerin (DB00727)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Transdermal nitroglycerin (GTN)
Study: 10904464
Drug: Warfarin sodium
Normalized name: Warfarin Sodium
DrugBank: Warfarin (DB00682)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Warfarin sodium (postoperative)
Study: 20683147
Drug: Elevated CRP
Normalized name: menthol
DrugBank: Menthol (DB14123)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Elevated CRP (top 15 percentile; CRP >= 2.09 mg/L)
Study: 25899750
Drug: Dopaminergic treatment
Normalized name: Hongo Killer Treatment
Approvals — FDA: no, EMA: no, PMDA: no
Description: Dopaminergic treatment (ON state)
Study: 16787687
Drug: docetaxel 75
Normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: docetaxel 75 mg/m2 plus cisplatin 75 mg/m2, every 3 weeks (DC)
Study: 31996370
Drug: PSA ≤
Normalized name: Prostate-Specific Antigen
Approvals — FDA: no, EMA: no, PMDA: no
Description: PSA ≤ 1 ng/mL, black men
Study: 12955634
Drug: 500 mg
Normalized name: bran 500 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: 500 mg levofloxacin per day for 10 days
Study: 6351957
Drug: sulphamethoxazole 1000
Normalized name: Sulphamethoxazole
DrugBank: Sulfamethoxazole (DB01015)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: sulphamethoxazole 1000 mg twice daily for 7 days
Study: 11749745
Drug: Active treatment
Normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Active treatment group
Study: 17127550
Drug: GABA medications
Normalized name: GABA
DrugBank: gamma-Aminobutyric acid (DB02530)
Approvals — FDA: no, EMA: no, PMDA: no
Description: GABA medications
Study: 9505990
Drug: Combination of
Normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
Approvals — FDA: no, EMA: no, PMDA: no
Description: Combination of butorphanol nasal spray (1 mg) and metoclopramide (10 mg)
Study: 16247099
Drug: North American
Normalized name: North American coral snake antivenin
DrugBank: Coral snake (micrurus fulvius) immune globulin antivenin (equine) (DB13883)
Approvals — FDA: no, EMA: no, PMDA: no
Description: North American ginseng extract (2 capsules per day for 4 months)
Study: 7582391
Drug: Mebhydroline (Omeril)
Normalized name: mebhydroline
Approvals — FDA: no, EMA: no, PMDA: no
Description: Mebhydroline (Omeril) 100 mg t.i.d.
Study: 27776458
Drug: Control group
Normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
Approvals — FDA: no, EMA: no, PMDA: no
Description: Control group (recommended sports brassiere, refraining from caffeine and methylxanthine-containing foods, and simple analgesics)
Study: 29549829
Drug: Dexmedetomidine 1
Normalized name: DEXMEDETOMIDINE 120MCG SUBLINGUAL FILM
Approvals — FDA: no, EMA: no, PMDA: no
Description: Dexmedetomidine 1 μg/kg bolus followed by 0.2-0.7 μg/kg/h infusion from induction of anesthesia to the end of surgery (group D1)
Study: 29549829
Drug: Dexmedetomidine 1
Normalized name: DEXMEDETOMIDINE 120MCG SUBLINGUAL FILM
Approvals — FDA: no, EMA: no, PMDA: no
Description: Dexmedetomidine 1 μg/kg bolus (group D2)
Study: 29601443
Drug: Digital Rectal
Normalized name: BD Thermometer Digital Rectal (obsolete)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Digital Rectal Examination (DRE)
Study: 2655367
Drug: Measurement of
Normalized name: OIL OF CAMPHOR
Approvals — FDA: no, EMA: no, PMDA: no
Description: Measurement of local anaesthetic agent removed from the isolated arm after 15 min
Study: 10577447
Drug: 200 mg
Normalized name: RNA 200 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: 200 mg candoxatril twice a day
Study: 31608389
Drug: Internet-delivered cognitive
Normalized name: DELIVER
Approvals — FDA: no, EMA: no, PMDA: no
Description: Internet-delivered cognitive therapy (CT)
Study: 10598693
Drug: Timolol (TIMOPTIC)
Normalized name: timolol
DrugBank: Timolol (DB00373)
Approvals — FDA: yes, EMA: no, PMDA: yes
Description: Timolol (TIMOPTIC) twice daily
Study: 10598693
Drug: Dorzolamide (TRUSOPT)
Normalized name: dorzolamide Ophthalmic Solution [Trusopt]
DrugBank: Dorzolamide (DB00869)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Dorzolamide (TRUSOPT) three times daily
Study: 7623395
Drug: Cognitive-behavioral group
Normalized name: Streptococcus viridans group
Approvals — FDA: no, EMA: no, PMDA: no
Description: Cognitive-behavioral group program with nicotine patches
Study: 21435408
Drug: HIV vaccine
Normalized name: AAV-2 HIV Vaccine
DrugBank: TGAAC09 (DB06363)
Approvals — FDA: no, EMA: no, PMDA: no
Description: HIV vaccine (RV144)
Study: 12586132
Drug: Unfractionated heparin
Normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Unfractionated heparin (UFH; 7500 anti-Xa U twice a day subcutaneous)
Study: 2709521
Drug: Polytetrafluoroethylene patch
Normalized name: polytetrafluoroethylene
Approvals — FDA: no, EMA: no, PMDA: no
Description: Polytetrafluoroethylene patch closure
Study: 12772814
Drug: Neoadjuvant chemotherapy
Normalized name: menthol
DrugBank: Menthol (DB14123)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Neoadjuvant chemotherapy followed by local‐regional radiotherapy
Study: 29563377
Drug: Heparin (bolus)
DrugBank: Heparin (DB01109)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Heparin (bolus)
Study: 24237691
Drug: Yohimbine HCl
Normalized name: yohimbine HCl
DrugBank: Yohimbine (DB01392)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Yohimbine HCl (10.8 mg)
Study: 18568228
Drug: Chemical treatment
Normalized name: Hongo Killer Treatment
Approvals — FDA: no, EMA: no, PMDA: no
Description: Chemical treatment
Study: 19474053
Drug: Nifedipine GITS
Normalized name: Nifedipine
DrugBank: Nifedipine (DB01115)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Nifedipine GITS 30-60 mg/day
Study: 15327583
Drug: 600 mg
Normalized name: mesna 600 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: 600 mg of Alpha-lipoic acid (ALA)
Study: 28492711
Drug: Triple therapy
Normalized name: MigreLief Triple Therapy with Puracol Caplet
Approvals — FDA: no, EMA: no, PMDA: no
Description: Triple therapy with curcumin
Study: 17203353
Drug: Serenoa repens
Normalized name: Serenoa Repens Fruit
DrugBank: Saw palmetto (DB14360)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Serenoa repens (SR) 320 mg per day
Study: 17203353
Drug: Tamsulosin (TAM)
DrugBank: Tamsulosin (DB00706)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Tamsulosin (TAM) 0.4 mg per day
Study: 12851511
Drug: Transdermal hormone
Normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Transdermal hormone replacement therapy (50 microg daily of 17beta-estradiol plus 10 mg dydrogesterone daily for 14 days of each 28-day cycle)
Study: 10541423
Drug: Fexofenadine HCl
Normalized name: fexofenadine HCl
DrugBank: Fexofenadine (DB00950)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Fexofenadine HCl 120 mg QD
Study: 2455170
Drug: Low-dose clonidine
Normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
Approvals — FDA: yes, EMA: no, PMDA: yes
Description: Low-dose clonidine (0.075 mg per day)
Study: 19526040
Drug: No therapy
Normalized name: Monistat Simple Therapy
Approvals — FDA: no, EMA: no, PMDA: no
Description: No therapy (Control)
Study: 30258217
Drug: Combination of
Normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
Approvals — FDA: no, EMA: no, PMDA: no
Description: Combination of two potent bNAbs (3BNC117 and 10-1074) administered at 30 mg kg-1 each
Study: 29403482
Drug: Pentavalent rotavirus
Normalized name: Vaccine product containing only live pentavalent Rotavirus antigen
Approvals — FDA: no, EMA: no, PMDA: no
Description: Pentavalent rotavirus vaccine (RV5)
Study: 16943400
Drug: 200 mg
Normalized name: RNA 200 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: 200 mg celecoxib twice daily
Study: 16943400
Drug: 400 mg
Normalized name: mesna 400 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: 400 mg celecoxib twice daily
Study: 15994623
Drug: Oral contraceptive
Normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Oral contraceptive (ethinyl estradiol 20 microg and levonorgestrel 100 microg)
Study: 17389559
Drug: Oral contraceptive
Normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Oral contraceptive
Study: 1389195
Drug: Blind oral
Normalized name: Io-Blend
Approvals — FDA: no, EMA: no, PMDA: no
Description: Blind oral intubation without the use of a laryngoscope (Group 2)
Study: 21936907
Drug: Restrictive red
Normalized name: acid red 35
Approvals — FDA: no, EMA: no, PMDA: no
Description: Restrictive red cell transfusion strategy (target hemoglobin of 70‐90 g/L)
Study: 21936907
Drug: Liberal red
Normalized name: acid red 35
Approvals — FDA: no, EMA: no, PMDA: no
Description: Liberal red cell transfusion strategy (target hemoglobin of 90‐110 g/L)
Study: 16467715
Drug: Esomeprazole 40
Normalized name: esomeprazole 40 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: Esomeprazole 40 mg twice daily
Study: 22136963
Drug: Intravenous lipid
Normalized name: guggul lipids
Approvals — FDA: no, EMA: no, PMDA: no
Description: Intravenous lipid emulsion containing eicosapentaenoic and docosahexaenoic acid
Study: 20617588
Drug: Prednisolone tablets
Normalized name: Prednisolone Tablets
DrugBank: Prednisolone acetate (DB15566)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Prednisolone tablets 1 mg/(kg x d), 2 times/d for 2 weeks, then gradually reducing; all-trans retinoic acid 10 mg, 3 times a day, oral
Study: 7799476
Drug: Sodium citrate
Normalized name: Sodium Citrate
DrugBank: Sodium nitrate (DB15952)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Sodium citrate (0.5 g kg‐1 body mass)
Study: 16461202
Drug: Indapamide SR
Normalized name: Indapamide
DrugBank: Indapamide (DB00808)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Indapamide SR (1.5 mg)
Study: 2455104
Drug: Pindolol 10
Normalized name: pindolol 10 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: Pindolol 10 mg per day
Study: 11642629
Drug: 9-valent conjugate
Normalized name: L1 protein, human papillomavirus type 31 vaccine
DrugBank: Human papillomavirus type 31 L1 capsid protein antigen (DB10310)
Approvals — FDA: no, EMA: no, PMDA: no
Description: 9-valent conjugate pneumococcal vaccine (conjugated to CRM197)
Study: 8751020
Drug: Intramuscular atropine
Normalized name: Atropine
DrugBank: Atropine (DB00572)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Intramuscular atropine (0.02 mg/kg)
Study: 26417901
Drug: Sublingual liquid
Normalized name: B Complex with B-12 Sublingual Liquid
Approvals — FDA: no, EMA: no, PMDA: no
Description: Sublingual liquid birch pollen preparation (SB) 10,000 AUN/ml
Study: 26417901
Drug: Sublingual liquid
Normalized name: B Complex with B-12 Sublingual Liquid
Approvals — FDA: no, EMA: no, PMDA: no
Description: Sublingual liquid birch pollen preparation (SB) 20,000 AUN/ml
Study: 26417901
Drug: Sublingual liquid
Normalized name: B Complex with B-12 Sublingual Liquid
Approvals — FDA: no, EMA: no, PMDA: no
Description: Sublingual liquid birch pollen preparation (SB) 40,000 AUN/ml
Study: 31226322
Drug: Tamoxifen 10mg
Normalized name: TAMOXIFEN 10MG/5ML SOLN,ORAL
DrugBank: Tamoxifen (DB00675)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Tamoxifen 10mg twice daily for 7 days starting 21 days after IUS insertion
Study: 22112008
Drug: Pro-recovery intervention
Normalized name: nioxin PRO CLINICAL SCALP RECOVERY KIT
Approvals — FDA: no, EMA: no, PMDA: no
Description: Pro-recovery intervention (treatment as usual plus recovery-promoting relationships and working practices)
Study: 10663897
Drug: Biofeedback treatment
Normalized name: Hongo Killer Treatment
Approvals — FDA: no, EMA: no, PMDA: no
Description: Biofeedback treatment for patients with rectocele (Group 1)
Study: 10520842
Drug: Oral hyoscyamine
Normalized name: hyoscyamine Oral Solution
Approvals — FDA: no, EMA: no, PMDA: no
Description: Oral hyoscyamine (0.25 mg)
Study: 16047027
Drug: Arginine supplementation
Normalized name: Arginine
DrugBank: Arginine (DB00125)
Approvals — FDA: yes, EMA: no, PMDA: yes
Description: Arginine supplementation (15 g/day for 4 weeks after pneumococcal vaccine)
Study: 10447220
Drug: Lifibrol therapy
Normalized name: Monistat Simple Therapy
Approvals — FDA: no, EMA: no, PMDA: no
Description: Lifibrol therapy
Study: 22268365
Drug: Irbesartan 300
Normalized name: irbesartan 300 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: Irbesartan 300 mg
Study: 29547978
Drug: Stimulant medication
Normalized name: Staphylococcus simulans
Approvals — FDA: no, EMA: no, PMDA: no
Description: Stimulant medication ON
Study: 29547978
Drug: Stimulant medication
Normalized name: Staphylococcus simulans
Approvals — FDA: no, EMA: no, PMDA: no
Description: Stimulant medication OFF
Study: 24200934
Drug: Chlorella supplementation
Normalized name: Chlorella emersonii extract
Approvals — FDA: no, EMA: no, PMDA: no
Description: Chlorella supplementation (8 g Chlorella/day/person; equivalent to 22.9 mg lutein/day/person)
Study: 17138156
Drug: Epinephrine infusion
Normalized name: Epinephrine
DrugBank: Epinephrine (DB00668)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Epinephrine infusion at 50 ng/kg per minute under sedation with nitrous oxide (30% inhalation)
Study: 17022854
Drug: IV dipyrone
Normalized name: dipyrone
DrugBank: Metamizole (DB04817)
Approvals — FDA: no, EMA: no, PMDA: no
Description: IV dipyrone 1 g
Study: 28479175
Drug: PCV13 without
Normalized name: Streptococcus pneumoniae serotype 14 capsular antigen diphtheria CRM197 protein conjugate vaccine
DrugBank: Streptococcus pneumoniae type 14 capsular polysaccharide diphtheria CRM197 protein conjugate antigen (DB10289)
Approvals — FDA: no, EMA: no, PMDA: no
Description: PCV13 without 2-phenoxyethanol in single-dose syringe (SDS)
Study: 25640577
Drug: Extracorporeal shockwave
Normalized name: ethanol
DrugBank: Ethanol (DB00898)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Extracorporeal shockwave therapy (1000 impulses)
Study: 16478902
Drug: Tetracaine plus
Normalized name: Tetracaine
DrugBank: Tetracaine (DB09085)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Tetracaine plus Morphine
Study: 30102493
Drug: One dose
Normalized name: Next Choice One Dose
DrugBank: Levonorgestrel (DB00367)
Approvals — FDA: yes, EMA: no, PMDA: yes
Description: One dose of measles vaccine
Study: 14974944
Drug: EC-MPS 720
Normalized name: 6 MP
DrugBank: Mercaptopurine (DB01033)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: EC-MPS 720 mg b.i.d.
Study: 10774861
Drug: 10 ml
Normalized name: Vial Empty 10 mL
Approvals — FDA: no, EMA: no, PMDA: no
Description: 10 ml 0.5% bupivacaine without corticosteroid
Study: 27895406
Drug: Simplified dyad
Normalized name: benzalkonium
DrugBank: Benzalkonium (DB11105)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Simplified dyad criteria (combination of proliferation and VS)
Study: 25814381
Drug: Medication-assisted therapy
Normalized name: Monistat Simple Therapy
Approvals — FDA: no, EMA: no, PMDA: no
Description: Medication-assisted therapy (buprenorphine or methadone)
Study: 23870611
Drug: Sarpogrelate CR
Normalized name: Sarpogrelate
DrugBank: Sarpogrelate (DB12163)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Sarpogrelate CR 300 mg administered in the fasted condition
Study: 23870611
Drug: Sarpogrelate CR
Normalized name: Sarpogrelate
DrugBank: Sarpogrelate (DB12163)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Sarpogrelate CR 300 mg administered after a high-fat breakfast
Study: 9866000
Drug: Vaginal gemeprost
Normalized name: gemeprost
DrugBank: Gemeprost (DB08964)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Vaginal gemeprost (1 mg every 3 h for a maximum of five doses in 24 h)
Study: 8270987
Drug: Mitomycin (MIT‐C)
Normalized name: Mitomycin
DrugBank: Mitomycin (DB00305)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Mitomycin (MIT‐C) 40 mg
Study: 8645625
Drug: Droloxifene 40
Normalized name: Droloxifene
DrugBank: Droloxifene (DB15641)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Droloxifene 40 mg o.d. (group 1)
Study: 19391153
Drug: Therapist flexibility
Normalized name: salicylic acid
DrugBank: Salicylic acid (DB00936)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Therapist flexibility in cognitive-behavioral therapy
Study: 15464489
Drug: Control group
Normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
Approvals — FDA: no, EMA: no, PMDA: no
Description: Control group (no prostacyclin treatment)
Study: 7608311
Drug: Isradipine-CR 5
Normalized name: isradipine 5 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: Isradipine-CR 5 mg
Study: 7608311
Drug: Isradipine-CR 10
Normalized name: isradipine 10 MG
Approvals — FDA: no, EMA: no, PMDA: no
Description: Isradipine-CR 10 mg
Study: 7608311
Drug: Isradipine-CR 20
Normalized name: Isradipine
DrugBank: Isradipine (DB00270)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Isradipine-CR 20 mg
Study: 25516380
Drug: Lamotrigine therapy
Normalized name: Lamotrigine
DrugBank: Lamotrigine (DB00555)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Lamotrigine therapy
Study: 19474264
Drug: Tetanus toxoid
Normalized name: Tetanus Toxoid
DrugBank: Clostridium tetani toxoid antigen (formaldehyde inactivated) (DB10583)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Tetanus toxoid vaccine
Study: 26309227
Drug: Intravenous methylprednisolone
Normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Intravenous methylprednisolone during radiotherapy for 14 days
Study: 7525038
Drug: Pamidronate 60
Normalized name: pamidronate 60 mg intravenous powder for injection
Approvals — FDA: no, EMA: no, PMDA: no
Description: Pamidronate 60 mg every 2 weeks
Study: 23593253
Drug: Ty21a vaccine
Normalized name: Typhoid Vaccine Live Ty21a
DrugBank: Typhoid Vaccine Live (DB11050)
Approvals — FDA: no, EMA: no, PMDA: no
Description: Ty21a vaccine
Study: 2882626
Drug: Acetylsalicylic acid
Normalized name: ACETYLSALICYLIC ACID
DrugBank: Acetylsalicylic acid (DB00945)
Approvals — FDA: yes, EMA: no, PMDA: no
Description: Acetylsalicylic acid (ASA) 1.5 g/day